Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Donnan G. A., Davis S. M., Chambers B. R., Gates P. C., Hankey G. J., McNeil J. J., Rosen D., Stewart-Wynne E. G., Tuck R. R. Trials of streptokinase in severe acute ischaemic stroke. Lancet. 1995 Mar 4;345(8949):578–579. [PubMed] [Google Scholar]
- Fisher M., Bogousslavsky J. Evolving toward effective therapy for acute ischemic stroke. JAMA. 1993 Jul 21;270(3):360–364. [PubMed] [Google Scholar]
- Hacke W., Kaste M., Fieschi C., Toni D., Lesaffre E., von Kummer R., Boysen G., Bluhmki E., Höxter G., Mahagne M. H. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA. 1995 Oct 4;274(13):1017–1025. [PubMed] [Google Scholar]
- Hommel M., Boissel J. P., Cornu C., Boutitie F., Lees K. R., Besson G., Leys D., Amarenco P., Bogaert M. Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet. 1995 Jan 7;345(8941):57–57. doi: 10.1016/s0140-6736(95)91179-0. [DOI] [PubMed] [Google Scholar]
- Sandercock P. Thrombolytic therapy for acute ischaemic stroke: promising, perilous, or unproven? Lancet. 1995 Dec 9;346(8989):1504–1505. doi: 10.1016/s0140-6736(95)92044-7. [DOI] [PubMed] [Google Scholar]